PubRank

P Kuusela

Author PubWeight™ 93.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fibronectin binds to Staphylococcus aureus. Nature 1978 4.39
2 Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta 1973 2.71
3 Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 2001 2.19
4 Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol 1993 2.13
5 Binding of human fibronectin to group A, C, and G streptococci. Infect Immun 1983 2.01
6 Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol 1984 1.98
7 Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol 1990 1.94
8 Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer 1986 1.91
9 The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol 1989 1.87
10 Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase. Infect Immun 1985 1.86
11 Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun 1992 1.66
12 Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer 1984 1.56
13 Functional mapping of the Yersinia enterocolitica adhesin YadA. Identification Of eight NSVAIG - S motifs in the amino-terminal half of the protein involved in collagen binding. Mol Microbiol 2000 1.55
14 Purification and characterisation of a plasmin-sensitive surface protein of Staphylococcus aureus. Eur J Biochem 1996 1.54
15 Immunological interspecies cross-reactions of fibroblast surface antigen (fibronectin). Immunochemistry 1976 1.44
16 The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. Br J Cancer 1994 1.44
17 Binding sites for streptococci and staphylococci in fibronectin. Infect Immun 1984 1.41
18 Isolation of a tryptic fragment containing the collagen-binding site of plasma fibronectin. J Biol Chem 1979 1.35
19 Affinity requirements for antibody assays mapped by monoclonal antibodies. J Immunol 1983 1.33
20 Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9. Int J Cancer 1987 1.30
21 Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med 1978 1.28
22 Polypeptides of a glycoprotein antigen (SF) present in serum and surface of normal but not of transformed chicken fibroblasts. Biochim Biophys Acta 1975 1.25
23 Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. J Supramol Struct 1976 1.23
24 Development of brown fat cells in monolayer culture. I. Morphological and biochemical distinction from white fat cells in culture. Exp Cell Res 1983 1.19
25 Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. Br J Cancer 1989 1.18
26 Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix. Infect Immun 1995 1.12
27 Interaction of Haemophilus influenzae with the mammalian extracellular matrix. J Infect Dis 1996 1.11
28 Expression of pls, a gene closely associated with the mecA gene of methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro. Infect Immun 2001 1.11
29 Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin. J Infect Dis 1992 1.10
30 A novel lectin-independent interaction of P fimbriae of Escherichia coli with immobilized fibronectin. FEBS Lett 1989 1.10
31 Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. Lab Invest 1988 1.10
32 The relationship between the keratocyst antigen (KCA) and keratin. J Oral Pathol 1986 1.06
33 Multifunctional nature of P fimbriae of uropathogenic Escherichia coli: mutations in fsoE and fsoF influence fimbrial binding to renal tubuli and immobilized fibronectin. Mol Microbiol 1991 1.03
34 CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br J Cancer 1994 1.03
35 Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. J Surg Oncol 1992 1.02
36 Demonstration and partial characterization of a novel soluble antigen present in keratocysts. Oncodev Biol Med 1982 0.98
37 Tumour markers CA 19-9 and CA 50 in digestive tract malignancies. Scand J Gastroenterol 1992 0.98
38 Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria. Methods 2000 0.97
39 Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. Eur J Cancer 1993 0.96
40 Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. Br J Cancer 1987 0.95
41 Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9. Anticancer Res 1996 0.94
42 Antibacterial activities of temporin A analogs. FEBS Lett 2000 0.91
43 Tumour marker CA 125 in patients with digestive tract malignancies. Scand J Clin Lab Invest 1991 0.89
44 Interleukin 1 receptor antagonist and E-selectin concentrations: a comparison in patients with severe acute pancreatitis and severe sepsis. J Crit Care 1999 0.89
45 Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg 1999 0.89
46 Proteolytic activity in leg ulcer exudate. Exp Dermatol 1993 0.89
47 Intramucosal pH and endotoxin and cytokine release in severe acute pancreatitis. Shock 2000 0.87
48 Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I. Pediatr Res 1994 0.86
49 Immobilization of plasminogen on Escherichia coli flagella. FEMS Microbiol Lett 1993 0.86
50 Activation of interstitial collagenase, MMP-1, by Staphylococcus aureus cells having surface-bound plasmin: a novel role of plasminogen receptors of bacteria. FEBS Lett 1999 0.84
51 Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein. Br J Obstet Gynaecol 1983 0.84
52 Is swimming exercise or cold exposure for rats? Acta Physiol Scand 1986 0.84
53 Tumour markers in pancreatic cancer. Ann Chir Gynaecol 1989 0.83
54 Predictive value of interleukins 6, 8 and 10, and low HLA-DR expression in acute renal failure. Clin Nephrol 2004 0.83
55 Exogenous fibronectin is not required for organogenesis in vitro. In Vitro 1983 0.82
56 Reactivity of hybridoma antibodies with amniotic and plasma fibronectin. Scand J Immunol 1980 0.81
57 Cellular origin of fibronectin in interspecies hybrid kidneys. J Cell Biol 1984 0.81
58 Beta-adrenergic stimulation of fatty acid release from brown fat cells differentiated in monolayer culture. Life Sci 1986 0.81
59 Comparison of genotypes of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in Finland. Eur J Clin Microbiol Infect Dis 2005 0.81
60 Noncollagenous matrix components of glomeruli in congenital nephrotic syndrome of the Finnish type: evidence of abnormal splitting of nidogen? Exp Nephrol 1997 0.81
61 Valgus deformity and proximal subluxation of the rheumatoid elbow: a radiographic 15 year follow up study of 148 elbows. Ann Rheum Dis 2001 0.81
62 Tissue interactions of Escherichia coli adhesins. Antonie Van Leeuwenhoek 1988 0.80
63 Synthesis and antimicrobial activity of the symmetric dimeric form of Temporin A based on 3-N,N-di(3-aminopropyl)amino propanoic acid as the branching unit. Bioorg Med Chem 2001 0.80
64 Comparison of synthesis and antibacterial activity of temporin A. FEBS Lett 1999 0.80
65 Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors. Pediatr Res 1995 0.80
66 Characterization of fibronectin on human spermatozoa. Hoppe Seylers Z Physiol Chem 1984 0.80
67 Endothelial tie receptor antigen in maternal and cord blood of healthy and preeclamptic subjects. Obstet Gynecol 1998 0.80
68 Adipose, muscle and lung tissue lipoprotein lipase activities in young streptozotocin treated rats. Horm Metab Res 1980 0.79
69 The cellular origin of fibronectin in the basement membrane zone of developing tooth. J Embryol Exp Morphol 1986 0.79
70 The ovarian cancer associated antigen CA 125 in patients with pleural effusions. Eur J Cancer Clin Oncol 1988 0.79
71 Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. A prospective study. Scand J Gastroenterol 1991 0.78
72 Plasma interleukin-8, interleukin-10, and E-selectin levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Microbiol Infect Dis 1997 0.78
73 Evaluation of three slide agglutination tests for rapid identification of Staphylococcus aureus. Acta Vet Scand 1991 0.78
74 Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Microbiol Infect Dis 1995 0.78
75 Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy. Br J Cancer 1990 0.78
76 Dental papilla cells synthesize but do not deposit fibronectin in culture. J Dent Res 1987 0.77
77 Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer 1995 0.77
78 Temperature responses of rats to treadmill exercise, and the effect of thermoregulatory capacity. Acta Physiol Scand 1982 0.77
79 Effects of the adrenergic nervous system on training-induced cardiac enlargement, and on the intrinsic rate and phenylephrine sensitivity of isolated rat atria. Can J Physiol Pharmacol 1982 0.76
80 Effect of chemical modification of arginine and lysine residues of fibronectin on its antigenic and gelatin-binding activity. Mol Immunol 1983 0.76
81 Isolation of a novel cell-attachment and spreading-promoting protein from human serum. Biochem J 1985 0.75
82 Biphasic reduction and concanavalin A binding properties of serum alpha-fetoprotein in preterm and term infants. J Pediatr 1991 0.75
83 Non-specific binding compromises the purification yields of leukemic B-cells in chronic lymphocytic leukemia: prevention by collagen coating. Eur J Haematol 1998 0.75
84 Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A-sepharose in pre-natal diagnosis of fetal malformations. Scand J Clin Lab Invest 1983 0.75
85 Tumour markers in pancreatic cancer. Scand J Gastroenterol Suppl 1986 0.75
86 The single chain nature of human group specific (Gc) protein. Biochim Biophys Acta 1972 0.75
87 Modification of training-induced responses by repeated norepinephrine injections in rats. J Appl Physiol Respir Environ Exerc Physiol 1982 0.75
88 Tumour markers in gastric cancer. Ann Chir Gynaecol 1989 0.75
89 Disulfide-bonded dimerization of fibronectin in vitro. Eur J Biochem 1991 0.75
90 No endotoxin detected in plasma of patients with ankylosing spondylitis. Ann Rheum Dis 1997 0.75
91 Early detection of malignant transformation after neonatal sacrococcygeal teratoma. Pediatr Hematol Oncol 1987 0.75